Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Obesity rates are down. Is that because of weight-loss drugs?
In addition, the decline in overall obesity rate reported by the CDC isn’t the first such drop. Between 1999 and 2018, the NHANES results found two instances of slight decreases in obesity rates and two dips in severe obesity rates. These falls were followed by steady increases in both categories.
Are Weight-Loss Drugs Contributing to a Fall in the Obesity Rate?
Results from a recent survey have prompted questions about the influence of GLP-1s on the obesity rate of U.S. adults.
Lilly to test obesity drugs to treat addiction in 2025
Eli Lilly and Co. will begin studies to see if its blockbuster weight-loss medicines are also effective at controlling addictive behaviors like alcohol abuse, smoking and drug addiction, Chief Executive Officer Dave Ricks said.
Lilly CEO predicts obesity-treatment Zepbound will become drugmaker’s top drug by 2025
David Ricks told a lunch audience at the Economic Club of Washington, D.C., that Zepbound could quickly become the most popular drug in the 148-year-old company’s history.
Lilly to Test Obesity Drugs to Treat Addiction in 2025, CEO Says
Eli Lilly & Co. will begin studies to see if its blockbuster weight-loss medicines are also effective at controlling addictive behaviors like alcohol abuse, smoking and drug addiction, Chief Executive Officer Dave Ricks said.
What can't weight-loss meds do? Eli Lilly is going to test Zepbound as a treatment for addiction
Eli Lilly (LLY), the pharma giant that produces the popular weight-loss drug Zepbound, said it plans to test the blockbuster drug as a treatment for alcohol and drug addiction starting next year.
Will Eli Lilly's blockbuster obesity drug be available in India in 2025?
Tirzepatide had received approval in a single-dose prefilled pen format in January 2024 for use as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes, provided
1d
on MSN
Swiss Re Says Too Early to Tell if Obesity Drugs Will Reshape Insurance
Weight-loss drugs could be a boon for insurers, but it is too soon to tell whether the industry will be transformed, the head ...
2d
How RFK Jr. Could Reverse Our Nation’s Illogical Approach To Obesity
Battling obesity requires a shift away from today’s reactive efforts. Enter Robert F. Kennedy Jr., the controversial nominee ...
5d
on MSN
Obesity has cost Americans a lot over the past three decades — physically and economically
One study shows two-thirds of Americans are overweight or obese, but better access to health care and health technology could ...
thelundreport
2d
Who gets obesity drugs covered by insurance? In North Carolina, it helps if you’re on Medicaid
But in a twist this August, a separate part of North Carolina’s government allowed the Medicaid program to start covering the ...
pharmaphorum
3h
Lilly adds another sales channel for obesity drug Zepbound
"Offering Zepbound single-dose vials…through another platform to LillyDirect will help ensure broader availability of ...
Psychology Today
7d
A Second Look at Obesity as a Disease
Such is the case with the current debate surrounding the concept of "
obesity
as a disease." To understand how we arrived at ...
New Atlas
3d
Breakthrough natural micropill targets obesity, diabetes and inflammation
An innovative combination of readily available natural products has shaped up to be an alternative to drugs like Ozempic to ...
BioPharma Dive
4d
BioAge shares tumble after decision to halt obesity drug study
The biotech disclosed Friday plans to terminate a Phase 2 study testing azelaprag with tirzepatide for weight loss following ...
Opinion
Calgary Herald on MSN
12h
Opinion
Ford: If obesity is a disease, promoting the cause of it has to stop
Why allow the very highly caloric, not-very-nutritious food tempt those into thus encouraging the disease? We are incessantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Eli Lilly
India
Tirzepatide
England
United Kingdom
Feedback